| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_597944ed73e5d1bf8eb2259470867e5b |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4406
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-513
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4985
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-53 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4985
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4406
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-513
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377 |
| filingDate |
2016-01-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9b194097344543fd03dbf40b85b83a1e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3258c322974880668506bc6f7e1f0e47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_60a6b26e3bef62c4bfa46d5e0742cc39
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ee52e9d5cf9b4660a55046a666d64393 |
| publicationDate |
2016-08-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2016120432-A1 |
| titleOfInvention |
Compounds and methods for anticoagulation therapy |
| abstract |
The invention relates to certain compounds that are inducers of Heat shock 70 kDa protein 1A/1B ( HSPA1A/B ) and their use for anticoagulation therapy; and to a method for anticoagulation therapy that comprises the administration of one of these inducer compounds. It has been here proved that induction of Heat shock 70 kDa protein 1A/1B by administration of one of these inducer compounds has antithrombotic effects without accelerating or altering bleeding time. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-115611864-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108409738-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-3112684-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022018256-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11787812-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108409738-B |
| priorityDate |
2015-01-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |